Page last updated: 2024-08-23

simvastatin and Interstitial Cell Tumor

simvastatin has been researched along with Interstitial Cell Tumor in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fu, Y; Peng, J; Tao, L; Wang, L; Wang, Q; Wu, D; Xu, C; Yu, M	1

Other Studies

1 other study(ies) available for simvastatin and Interstitial Cell Tumor

Article	Year
Simvastatin-induced up-regulation of gap junctions composed of connexin 43 sensitize Leydig tumor cells to etoposide: an involvement of PKC pathway. Toxicology, 2013, Oct-04, Volume: 312 Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Communication; Cell Line, Tumor; Cell Survival; Connexin 43; Etoposide; Gap Junctions; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leydig Cell Tumor; Mice; Protein Kinase C; Simvastatin; Up-Regulation	2013

Article

Year

Simvastatin-induced up-regulation of gap junctions composed of connexin 43 sensitize Leydig tumor cells to etoposide: an involvement of PKC pathway.

Toxicology, 2013, Oct-04, Volume: 312

Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Communication; Cell Line, Tumor; Cell Survival; Connexin 43; Etoposide; Gap Junctions; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leydig Cell Tumor; Mice; Protein Kinase C; Simvastatin; Up-Regulation

2013